chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: rash at the injection site, rash that looked like a little bump on the right side of the arm; headache; fatigue; soreness; swelling at the injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness) and VACCINATION SITE SWELLING (swelling at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A, Unknown and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lung cancer (Patient is a cancer survivor with a past medical history of stage 4 lung cancer (only left side of lung was involved) and vocal cord damage) in 2013. Concurrent medical conditions included Arthritis. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, ALPRAZOLAM (XANAX) for Breathing arrested, PREDNISONE for Breathing difficult, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for COPD, ONDANSETRON (ZOFRAN ZYDIS) for Nausea, OXYGEN, GUAIFENESIN (MUCINEX), MONTELUKAST SODIUM (SINGULAIR), APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (BAYER ASPIRIN REGIMEN), PARACETAMOL (TYLENOL ARTHRITIS), ERGOCALCIFEROL (VITAMIN D2) and OXYCODONE for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.            Concomitant medication also includes Antibiotics taken once daily to clear out the lungs and prevent pneumonia, Fentanyl with Saline for unknown indication . Patient says she applied Cortaid on injection site and the rash went away   This case was linked to MOD-2021-294272 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: rash at the injection site, rash that looked like a little bump on the right side of the arm; headache; fatigue; soreness; swelling at the injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness) and VACCINATION SITE SWELLING (swelling at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A, Unknown and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lung cancer (Patient is a cancer survivor with a past medical history of stage 4 lung cancer (only left side of lung was involved) and vocal cord damage) in 2013. Concurrent medical conditions included Arthritis. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, ALPRAZOLAM (XANAX) for Breathing arrested, PREDNISONE for Breathing difficult, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for COPD, ONDANSETRON (ZOFRAN ZYDIS) for Nausea, OXYGEN, GUAIFENESIN (MUCINEX), MONTELUKAST SODIUM (SINGULAIR), APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (BAYER ASPIRIN REGIMEN), PARACETAMOL (TYLENOL ARTHRITIS), ERGOCALCIFEROL (VITAMIN D2) and OXYCODONE for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE RASH (rash at the injection site, rash that looked like a little bump on the right side of the arm), HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.            Concomitant medication also includes Antibiotics taken once daily to clear out the lungs and prevent pneumonia, Fentanyl with Saline for unknown indication . Patient says she applied Cortaid on injection site and the rash went away   This case was linked to MOD-2021-294272 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered from a vial that was left out of the fridge for over 12 hours after being punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered from a vial that was left out of the fridge for over 12 hours after being punctured) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered from a vial that was left out of the fridge for over 12 hours after being punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered from a vial that was left out of the fridge for over 12 hours after being punctured) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment medication was not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Illness, Pyrexia
Clinical narrative: ill for a day; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M21A and 015C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: STEROIDS in 2019. Concurrent medical conditions included COPD.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue) had resolved.            No concurrent medication was reported by patient.  No treatment medication was reported by patient.   This case was linked to MOD-2021-294246 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Red blood cell count decreased, White blood cell count
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Off label use) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Arthritis and Anaemia. Concomitant products included CELECOXIB (CELEBREX) for Arthritis.On 22-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced OFF LABEL USE (Off label use). In August 2021, OFF LABEL USE (Off label use) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available)On an unknown date, Red blood cell count decreased: low (Low) Anemic. On an unknown date, White blood cell count: low (Low) Low.Patient states that also she takes an unknown medication to treat anemia and her healthcare provider advised her to get the third dose out of caution due to the medical conditions she has received third dose. She received first dose on JAN 2021 and Second dose on 09FEB2021. No concomitant medications were provided by reporter. No treatment medications were provided by reporter.Reporter did not allow further contact
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Feeding disorder, Headache, Illness
Clinical narrative: Headache; Nauseated; can hardly eat anything/can only eat a little bit at a time; feel bloated; she got sick gain/got really sick in her stomach; her stomach hurt/had stomach ache/her stomach was hurting really bad; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad) and NAUSEA (Nauseous) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food poisoning (Chick-fil-a).    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad) and NAUSEA (Nauseous). On an unknown date, the patient experienced HEADACHE (Headache) and NAUSEA (Nauseated). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad), NAUSEA (Nauseous), HEADACHE (Headache) and NAUSEA (Nauseated) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient had Chick-fil-A. Daughter has not seen a doctor or received any treatment for it. Daughter has headache on and off and takes Tylenol for her headache, but her headache is not related to the vaccine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Headache; Nauseated; can hardly eat anything/can only eat a little bit at a time; feel bloated; she got sick gain/got really sick in her stomach; her stomach hurt/had stomach ache/her stomach was hurting really bad; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad) and NAUSEA (Nauseous) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food poisoning (Chick-fil-a).    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad) and NAUSEA (Nauseous). On an unknown date, the patient experienced HEADACHE (Headache) and NAUSEA (Nauseated). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (can hardly eat anything/can only eat a little bit at a time), ABDOMINAL DISTENSION (feel bloated), ILLNESS (she got sick gain/got really sick in her stomach), ABDOMINAL PAIN UPPER (her stomach hurt/had stomach ache/her stomach was hurting really bad), NAUSEA (Nauseous), HEADACHE (Headache) and NAUSEA (Nauseated) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient had Chick-fil-A. Daughter has not seen a doctor or received any treatment for it. Daughter has headache on and off and takes Tylenol for her headache, but her headache is not related to the vaccine.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in her arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in her arm). At the time of the report, PAIN IN EXTREMITY (soreness in her arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Interchange of vaccine products
Clinical narrative: First dose Moderna/Second dose pfizer; I already had the virus way back in February; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna/Second dose pfizer) and COVID-19 (I already had the virus way back in February) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. In February 2021, the patient experienced COVID-19 (I already had the virus way back in February). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna/Second dose pfizer). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna/Second dose pfizer) and COVID-19 (I already had the virus way back in February) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up was received. Reporter contact information and event- COVID-19 were added
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: COVID Arm after first vaccine; Hot Left arm Injection Site after first vaccine; Red Left arm Injection Site after first vaccine; Pain Injection Site Left Arm  after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID Arm after first vaccine), VACCINATION SITE WARMTH (Hot Left arm Injection Site after first vaccine), VACCINATION SITE ERYTHEMA (Red Left arm Injection Site after first vaccine) and VACCINATION SITE PAIN (Pain Injection Site Left Arm  after first vaccine) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced VACCINATION COMPLICATION (COVID Arm after first vaccine), VACCINATION SITE WARMTH (Hot Left arm Injection Site after first vaccine), VACCINATION SITE ERYTHEMA (Red Left arm Injection Site after first vaccine) and VACCINATION SITE PAIN (Pain Injection Site Left Arm  after first vaccine). On 22-Jul-2021, VACCINATION COMPLICATION (COVID Arm after first vaccine), VACCINATION SITE WARMTH (Hot Left arm Injection Site after first vaccine) and VACCINATION SITE ERYTHEMA (Red Left arm Injection Site after first vaccine) had resolved. On 24-Jul-2021, VACCINATION SITE PAIN (Pain Injection Site Left Arm  after first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-294351 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Cough, Diarrhoea, Nasal congestion
Clinical narrative: Contracted COVID after vaccination; Lost of smell; Congestions; Cough; Diarrhea; Nausea; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Contracted COVID after vaccination), ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), COUGH (Cough) and DIARRHOEA (Diarrhea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jul-2021, the patient experienced ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting). 30-Jul-2021, the patient experienced COUGH (Cough). On an unknown date, the patient experienced COVID-19 (Contracted COVID after vaccination). At the time of the report, COVID-19 (Contracted COVID after vaccination), ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), COUGH (Cough), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. Patient reported that she self-isolated and treated it like normal cold symptoms   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow-up received and it contains non-significant information.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test, Vomiting
Clinical narrative: Contracted COVID after vaccination; Lost of smell; Congestions; Cough; Diarrhea; Nausea; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Contracted COVID after vaccination), ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), COUGH (Cough) and DIARRHOEA (Diarrhea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jul-2021, the patient experienced ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting). 30-Jul-2021, the patient experienced COUGH (Cough). On an unknown date, the patient experienced COVID-19 (Contracted COVID after vaccination). At the time of the report, COVID-19 (Contracted COVID after vaccination), ANOSMIA (Lost of smell), NASAL CONGESTION (Congestions), COUGH (Cough), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. Patient reported that she self-isolated and treated it like normal cold symptoms   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow-up received and it contains non-significant information.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided by reporter. Treatment information not provided by reporter.   This case was linked to MOD-2021-294436 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Vaccinated neighbors that got covid-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Vaccinated neighbors that got covid-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Vaccinated neighbors that got covid-19). At the time of the report, COVID-19 (Vaccinated neighbors that got covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was provided.  No treatment medications was provided.   This case was linked to MOD-2021-294379 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Due for second dose on 24-AUG-2021 but having diarrhea from 23-AUG-2021 No concomitant medications reported. No treatment information was reported by reporter   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Off label use
Clinical narrative: Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19; Was scheduled to receive the 2nd dose on 20-Aug-2021; the doctor said they should wait 90 days after the symptoms are gone; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) and OFF LABEL USE (Was scheduled to receive the 2nd dose on 20-Aug-2021; the doctor said they should wait 90 days after the symptoms are gone) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) and OFF LABEL USE (Was scheduled to receive the 2nd dose on 20-Aug-2021; the doctor said they should wait 90 days after the symptoms are gone). At the time of the report, COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) outcome was unknown and OFF LABEL USE (Was scheduled to receive the 2nd dose on 20-Aug-2021; the doctor said they should wait 90 days after the symptoms are gone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated that he and his wife scheduled to receive the 2nd dose on 20 Aug 2021, but their doctor said they should wait 90 days after their symptoms are gone.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   This case was linked to MOD-2021-294322 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: very hot in the area of the injection; weal appeared in the injection site; weal appeared in the injection site that was a little swollen; palpitations; pain in the injection arm to the middle of her elbow; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), VACCINATION SITE WARMTH (very hot in the area of the injection), VACCINATION SITE ERYTHEMA (weal appeared in the injection site), VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Aug-2021, the patient experienced PALPITATIONS (palpitations) and VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow). On 22-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (weal appeared in the injection site) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen). On 23-Aug-2021, the patient experienced VACCINATION SITE WARMTH (very hot in the area of the injection). On 15-Aug-2021, PALPITATIONS (palpitations) had resolved. On 17-Aug-2021, VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow) had resolved. At the time of the report, VACCINATION SITE WARMTH (very hot in the area of the injection), VACCINATION SITE ERYTHEMA (weal appeared in the injection site) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Pill for depression to help sleep.  No treatment information was mentioned.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Had her 1st dose of the Moderna COVID-19 Vaccine on 30-Mar-2021 but had not gotten 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Had her 1st dose of the Moderna COVID-19 Vaccine on 30-Mar-2021 but had not gotten 2nd dose yet) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Had her 1st dose of the Moderna COVID-19 Vaccine on 30-Mar-2021 but had not gotten 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Had her 1st dose of the Moderna COVID-19 Vaccine on 30-Mar-2021 but had not gotten 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment information was not provided.  Patient wanted to know if she could get the 2nd dose or had to start over.   Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Feeling cold, Heart rate, Nausea
Clinical narrative: After 6 days later, his head had a funny feeling with weird sensation; He felt really cold; He was shaking really bad; He had nausea; He had chills.; He had a sore right arm on that day.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (He had a sore right arm on that day.), FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad) and NAUSEA (He had nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was provided.     On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced PAIN IN EXTREMITY (He had a sore right arm on that day.). On 21-Aug-2021, the patient experienced FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad), NAUSEA (He had nausea) and CHILLS (He had chills.). At the time of the report, PAIN IN EXTREMITY (He had a sore right arm on that day.), FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad), NAUSEA (He had nausea) and CHILLS (He had chills.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Aug-2021, Heart rate: increased (abnormal) Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Pain medicines were taken as concomitant medication.  Treatment medication was not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Tremor
Clinical narrative: After 6 days later, his head had a funny feeling with weird sensation; He felt really cold; He was shaking really bad; He had nausea; He had chills.; He had a sore right arm on that day.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (He had a sore right arm on that day.), FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad) and NAUSEA (He had nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was provided.     On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced PAIN IN EXTREMITY (He had a sore right arm on that day.). On 21-Aug-2021, the patient experienced FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad), NAUSEA (He had nausea) and CHILLS (He had chills.). At the time of the report, PAIN IN EXTREMITY (He had a sore right arm on that day.), FEELING ABNORMAL (After 6 days later, his head had a funny feeling with weird sensation), FEELING COLD (He felt really cold), TREMOR (He was shaking really bad), NAUSEA (He had nausea) and CHILLS (He had chills.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Aug-2021, Heart rate: increased (abnormal) Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Pain medicines were taken as concomitant medication.  Treatment medication was not provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose 29MAR2021 and Second dose 10May2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 29MAR2021 and Second dose 10May2021) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 29MAR2021 and Second dose 10May2021). On 10-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 29MAR2021 and Second dose 10May2021) had resolved.            No concomitant medications were provided by reporter.  No treatment medications were provided by reporter.  The patient needed a vaccine replacement card.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A patient received the first dose of the vaccine and it was an expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient received the first dose of the vaccine and it was an expired vaccine) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient received the first dose of the vaccine and it was an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient received the first dose of the vaccine and it was an expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up received on 23-AUG-2021 patient demographics, lot number was updated.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Rash macular, Vaccination site rash
Clinical narrative: some lingering muscular pain in my arm; two red 'blotches' near the injection site; a slight rash that was more pronounced after a shower; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (two red 'blotches' near the injection site), VACCINATION SITE RASH (a slight rash that was more pronounced after a shower) and MYALGIA (some lingering muscular pain in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced RASH MACULAR (two red 'blotches' near the injection site) and VACCINATION SITE RASH (a slight rash that was more pronounced after a shower). On an unknown date, the patient experienced MYALGIA (some lingering muscular pain in my arm). At the time of the report, RASH MACULAR (two red 'blotches' near the injection site), VACCINATION SITE RASH (a slight rash that was more pronounced after a shower) and MYALGIA (some lingering muscular pain in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Inappropriate schedule of product administration, Influenza
Clinical narrative: Flu symptoms; Lightheadedness; Loss of balance, Losing balance when he is walking; Inappropriate shedule of vaccine administartion; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness), BALANCE DISORDER (Loss of balance, Losing balance when he is walking) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A, 029L20A and 026L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL), AMIODARONE, APIXABAN (ELIQUIS), ATORVASTATIN, DUPILUMAB (DUPIXENT), ADALIMUMAB (HUMIRA), LISINOPRIL, OMEPRAZOLE and VITAMINS NOS for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness), BALANCE DISORDER (Loss of balance, Losing balance when he is walking) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion). At the time of the report, INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness) and BALANCE DISORDER (Loss of balance, Losing balance when he is walking) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion) had resolved.            No treatment information was provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Ligament rupture, Magnetic resonance imaging, Muscle atrophy, Muscular weakness
Clinical narrative: More than 7 months from the first shot and had not received the second shot; Weakness in the left shoulder; Thorn ligament left shoulder; Left rotator cuff muscles atrophy; Not able to raise the left arm; Pain on the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCULAR WEAKNESS (Weakness in the left shoulder), LIGAMENT RUPTURE (Thorn ligament left shoulder), MUSCLE ATROPHY (Left rotator cuff muscles atrophy), INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) and VACCINATION SITE PAIN (Pain on the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neurologic disorder NOS (Nerve problems in the neck).    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Dec-2020, the patient experienced MUSCULAR WEAKNESS (Weakness in the left shoulder), LIGAMENT RUPTURE (Thorn ligament left shoulder), MUSCLE ATROPHY (Left rotator cuff muscles atrophy), INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) and VACCINATION SITE PAIN (Pain on the injection site). On 23-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 7 months from the first shot and had not received the second shot). On 23-Jan-2021, VACCINATION SITE PAIN (Pain on the injection site) had resolved. On 24-Jan-2021, INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) had resolved. On 23-Aug-2021, PRODUCT DOSE OMISSION ISSUE (More than 7 months from the first shot and had not received the second shot) had resolved. At the time of the report, MUSCULAR WEAKNESS (Weakness in the left shoulder) had not resolved and LIGAMENT RUPTURE (Thorn ligament left shoulder) and MUSCLE ATROPHY (Left rotator cuff muscles atrophy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Dec-2020, Magnetic resonance imaging: abnormal (abnormal) MRI of the neck and shoulder revealed torn ligament and left rotator cuff muscle atrophy. On 24-Dec-2020, X-ray: abnormal (abnormal) X-ray of the neck and shoulder revealed torn ligament and left rotator cuff muscle atrophy.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment information was not provided.  As of 23-Aug-2021, patient had full range of motion in the affected arm. but he still has a weak shoulder
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination site pain, X-ray
Clinical narrative: More than 7 months from the first shot and had not received the second shot; Weakness in the left shoulder; Thorn ligament left shoulder; Left rotator cuff muscles atrophy; Not able to raise the left arm; Pain on the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCULAR WEAKNESS (Weakness in the left shoulder), LIGAMENT RUPTURE (Thorn ligament left shoulder), MUSCLE ATROPHY (Left rotator cuff muscles atrophy), INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) and VACCINATION SITE PAIN (Pain on the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neurologic disorder NOS (Nerve problems in the neck).    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Dec-2020, the patient experienced MUSCULAR WEAKNESS (Weakness in the left shoulder), LIGAMENT RUPTURE (Thorn ligament left shoulder), MUSCLE ATROPHY (Left rotator cuff muscles atrophy), INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) and VACCINATION SITE PAIN (Pain on the injection site). On 23-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 7 months from the first shot and had not received the second shot). On 23-Jan-2021, VACCINATION SITE PAIN (Pain on the injection site) had resolved. On 24-Jan-2021, INJECTED LIMB MOBILITY DECREASED (Not able to raise the left arm) had resolved. On 23-Aug-2021, PRODUCT DOSE OMISSION ISSUE (More than 7 months from the first shot and had not received the second shot) had resolved. At the time of the report, MUSCULAR WEAKNESS (Weakness in the left shoulder) had not resolved and LIGAMENT RUPTURE (Thorn ligament left shoulder) and MUSCLE ATROPHY (Left rotator cuff muscles atrophy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Dec-2020, Magnetic resonance imaging: abnormal (abnormal) MRI of the neck and shoulder revealed torn ligament and left rotator cuff muscle atrophy. On 24-Dec-2020, X-ray: abnormal (abnormal) X-ray of the neck and shoulder revealed torn ligament and left rotator cuff muscle atrophy.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment information was not provided.  As of 23-Aug-2021, patient had full range of motion in the affected arm. but he still has a weak shoulder
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Palpitations, Product dose omission issue
Clinical narrative: "an awful side effect"; a severe racing heart palpitations; not receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("an awful side effect"), PALPITATIONS (a severe racing heart palpitations) and PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL ("an awful side effect"), PALPITATIONS (a severe racing heart palpitations) and PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose). At the time of the report, FEELING ABNORMAL ("an awful side effect") and PALPITATIONS (a severe racing heart palpitations) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient in Feb experienced "an awful side effect" 12 hours after vaccination patient experienced a severe racing heart palpitations and went to the ER .The symptoms are not ongoing. Patient wanted to receive the 2nd dose anyway. Patient stated that it was told her not to receive the 2nd shot   No concomitant medication was reported. The treatment information was unknown.